Who
Richard A. Paulson
President and CEO
Company insider
Files Form 4 as: President and CEO, Karyopharm Therapeutics; Director, bluebird bio.
In numbers
- Trades disclosed
- 71
- Buys
- 0
- Sells
- 43
- Bought
- $0
- Sold
- $1.0M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 5 Mar 2020
- Last trade
- 14 May 2026
- Last filed
- 15 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 15 May 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $21K2,203 at $9.50 | filing |
| 14 May 2026filed 15 May 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $21K2,203 at $9.50 | filing |
| 13 May 2026filed 15 May 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —4,920 at $0.00 | filing |
| 13 May 2026filed 15 May 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —4,920 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $116K12,361 at $9.41 | filing |
| 2 Mar 2026filed 3 Mar 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $116K12,361 at $9.41 | filing |
| 5 Feb 2026filed 9 Feb 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —81,060 at $0.00 | filing |
| 5 Feb 2026filed 9 Feb 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —81,060 at $0.00 | filing |
| 15 Oct 2025filed 16 Oct 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —114,285 at $0.00 | filing |
| 15 Sep 2025filed 16 Sep 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $8,0831,257 at $6.43 | filing |
| 12 Sep 2025filed 16 Sep 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,800 at $0.00 | filing |
| 2 Jun 2025filed 3 Jun 2025 | bluebird bio | SEC FORM 4 Code D | —1,323 | filing |
| 30 May 2025filed 3 Jun 2025 | bluebird bio | SEC FORM 4 Code U | —155 | filing |
| 6 May 2025filed 7 May 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,680236 at $7.12 | filing |
| 4 Apr 2025filed 7 Apr 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $916245 at $3.74 | filing |
| 4 Mar 2025filed 6 Mar 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $74K11,694 at $6.29 | filing |
| 28 Feb 2025filed 4 Mar 2025 | KPTI Karyopharm Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 28 Feb 2025filed 4 Mar 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 4 Feb 2025filed 5 Feb 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,6644,099 at $0.65 | filing |
| 6 Jan 2025filed 7 Jan 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,1634,055 at $0.78 | filing |
News
No headline names them, or the companies they trade most, lately.